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Graphical Abstract 
 
Highlights: 
 WWTP effluent contains up to 20 mg/L dissolved non-biodegradable organic matter 
 IEX can remove the humic acid fraction of effluent organic matter 
 IEX+UV/H2O2 is robust process for pharmaceuticals removal from effluent 
 After IEX, UV/H2O2 can be operated at a low dose of 300 mJ/cm2 
 The energy demand of the UV/H2O2 process decreases by 84% after IEX 
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ozone/biofiltration, energy demand. 
Abstract 
Wastewater treatment plants (WWTPs) throughout the Netherlands contain significant 
concentrations of pharmaceuticals (25-65 μg/L) and about 10-20 mg C/L dissolved non-
biodegradable organic matter. By means of IEX mainly the humic acid fraction of the effluent 
organic matter can be removed, whereas O3/biofiltration mainly removes the hydrophobic 
fraction. For the first time the combination of these processes with O3/H2O2, UV/H2O2 or 
UV/O3 was tested for the removal of pharmaceuticals from wastewater effluent. Based on 
initial laboratory experiments, a pilot installation was built in which IEX followed by 
UV/H2O2 was applied to real WWTP effluent. The process appeared to be very robust, and 
able to remove a very broad range of different pharmaceuticals. The additional costs for this 
treatment are estimated at approximately €0.34/m3-treated effluent, which is in the same order 
of magnitude as estimated for other additional, but less versatile, treatment processes. 
1. Introduction 
Surface waters often contain a broad variety of organic micropollutants, like pesticides, 
industrial compounds, personal care products, steroid hormones, drugs of abuse and 
pharmaceuticals [1]. Increasing attention is being paid to pharmaceuticals, as these 
compounds have been produced to affect living organisms at low concentrations. Many 
pharmaceuticals are very well soluble in water, partly because that makes it easier to 
administer them, partly also because the European REACH regulation stimulates the use of 
polar compounds [2]. Besides, little is known on the effect of long term exposure and of the 
presence of mixtures of pharmaceuticals. Their toxicity towards certain aquatic organisms, 
however, has clearly been demonstrated [3-5]. It is expected that the number and amounts of 
pharmaceuticals used will increase significantly in the coming years, due to demographic 
changes and climate change [6]. The major part of these compounds and their metabolites 
appear to leave the body via urine and feces, and thus will end up in municipal wastewater. 
However, wastewater treatment plants in general are designed to remove COD, nitrogen and 
phosphorous. On average WWTPs remove about 60-70% of the pharmaceuticals, but the 
removal of individual compounds can vary between 0 and 100%. The remaining 
pharmaceuticals end up in surface waters, where they can adversely affect the aquatic 
environment and may cause problems for drinking wate r production. In the river Meuse, it 
was found that the summed concentrations of a series of pharmaceuticals and their 
transformation products range from 4 to 38 μg/L [7]. From this study, it was concluded that 
90% of the total pharmaceuticals load was determined by approximately 10 compounds and 
the other 10% comprised over 30 chemicals. Pharmaceuticals are not regulated at the moment 
in the EU, but in the 2013 amendment of the Environmental Quality Standards Directive 
(2008/105/EC) contains a mechanism to collect high-quality data on concentration of 
compounds of environmental concern, the so-called Watchlist. This list includes diclofenac, 
17-Beta-estradiol (E2), and 17-Alpha-ethinylestradiol (EE2). For compounds on this list it is 
likely that regulations will be developed in future. This would mean that additional treatment 
of wastewater will be necessary to comply with these regulations. The Dutch Water Boards 
want to be prepared for this situation. Therefore, an increasing number of research projects is 
being done into additional treatment steps for municipal wastewater. Examples are the use of 
activated carbon and of ozone [8-10]. Activated carbon is less effective for the adsorption of 
very hydrophilic, water soluble compounds [11], especially in case competition with more 
hydrophobic compounds like effluent organic matter occurs. In the Netherlands the use of 
ozone for drinking water treatment is limited because of the relatively high bromide 
concentrations in Dutch surface waters, as bromide is easily converted into the known 
carcinogenic bromate [12]. Besides, ozone preferably reacts with electron rich molecules, so 
not all pharmaceuticals thus can be degraded. 
For drinking water production, advanced oxidation processes, e.g. based on UV/H2O2, have 
been proven to be very successful in dealing with a broad range of organic micropollutants 
[13-15]. However, WWTP effluent contains much more organic matter than drinking water. 
This organic material competes with the micropollutants in oxidation processes, as a result of 
which these processes will become less effective for removing micropollutants [1, 16]. 
Besides, in UV/H2O2 processes a high UV dose is required, typically around 500 mJ/cm
2, 
whereas for disinfection in general 20-70 mJ/cm2 is sufficient. Because of the low UV 
transmittance of the effluent, the energy demand to reach such high doses will be very high. 
Therefore, it was studied whether the process can be optimized by removal of (part of) the 
Effluent Organic Material (EfOM) prior to the application of AOP. And although the EfOM 
removal processes and AOP are not novel techniques, it is for the first time that this 
combination is tested on treated wastewater effluent. 
First, the EfOM was characterized and concentrations of a broad range of pharmaceuticals in 
Dutch WWTP effluents throughout the country were studied. Characterization of EfOM can 
be done in various ways. In principle EfOM consists of soluble non-biodegradable organic 
matter. A common method to characterize organic material is by means of LC-OCD 
techniques, which can (semi-)quantitatively determine the following fractions [17, 18]: 
 Biopolymers (BP) with molecular weight (MW) >> 20.000 
 Humic substances (HS) with MW ≈ 1000 
 “Building blocks” (BB) with MW ≈ 300-500 (These are natural conversion products of 
humic substances) 
 Neutral components with MW < 350 (LMWn) 
 Acidic components (LMW-acids) with MW < 350 (LMWa)  
 Hydrophobic organic compounds (HOC) (=DOC-BP-HS-BB-LMWn-LMWa) 
 
According to Shon et al. EfOM contains 50% proteins, 40% carbohydrates, 10% fats and oils, 
and traces (≤ μg/L) of organic micropollutants [19]. In the present research, the LC-OCD 
method was applied. Additionally, the occurrence of a broad range of pharmaceuticals in the 
wastewater was determined. 
Subsequently, in one particular wastewater two different techniques were applied to remove 
part of the EfOM: anion exchange (IEX), and ozone followed by biofiltration. It was decided 
to apply IEX as a pretreatment, and the effect of this pretreatment on a subsequent UV/H2O2 
advanced oxidation process was studied both on laboratory and pilot scale. Although in 
principle advanced oxidation can result in total mineralization of the organic compounds, in 
most cases the degradation will occur to a lesser extent. In general, it is assumed that these 
(smaller) molecules will be better biodegradable [16]. However, it cannot be excluded that 
transformation products will be formed that might be even more toxic and/or persistent than 
their parent compounds [1], and thus should be taken into consideration too. To obtain 
information on this, the fate of some known metabolites during the treatment was studied too. 
 
2. Materials and methods 
 2.1 Samples from WWTP effluents 
 
Effluent samples were taken at various WWTPs throughout the Netherlands (Figure 1). The 
samples were collected with an automatic sample collector over 24 hours and proportional to 
the effluent flow rate, after several days of dry weather. 
 
 
 
Figure 1: WWTPs studied. 
 
TOC (Total Organic Carbon), DOC (Dissolved Organic Carbon) and UV-T (UV transmission 
at 254 nm) were measured at the KWR laboratory, and concentrations of a broad range of 
pharmaceuticals and some metabolites were measured according to the UPLC-MS/MS 
method described previously [13, 20]. The composition of the EfOM was determined by 
DOC-Labor Dr. Huber (Eisenbahnstr. 6, 76229 Karlsruhe, Germany), applying an LC-OCD 
method. 
 
2.2 Laboratory experiments 
 
Batch tests with the effluents of Panheel and Roermond had shown that the Lanxess S6368A 
resin (a strong base polystyrene) gave good results for EfOM removal. 300 L of water was 
filtrated over 10 L of resin at a flow of 10 bed volumes/min. For ozone/biofiltration different 
concentrations of ozone (0.15, 0.3 and 0.5 g O3/g COD) were added to the effluent, followed 
by filtration over a biofilter (based on lignite coke carrying a biofilm) with a residence time of 
15 or 30 min. 
The laboratory experiments were conducted with effluent of WWTP Panheel, which was 
collected as a 24-hour flow proportional sample.  Advanced oxidation experiments were 
carried out after pretreatment with 15.3 mg O3/L (i.e. 0.3 g O3/g COD) and a hydraulic 
retention time (HRT) in the biofilter of 15 min. IEX was applied using a column filled with 
Lewatit S6368A, provided by Lanxess AG (Kennedyplatz 1, 50569 Cologne, Germany). 
A mixture of over 30 pharmaceuticals was added according to the method described in [13, 
20], at concentrations of 1 – 5 µg/L (100 * the reporting limit of the analysis), as 
concentrations in WWTP effluent may show variations, and the concentrations had to be high 
enough to be able to determine their degradation. Metabolites were analyzed, but had not been 
dosed to the water. 10 mg/L H2O2 (JT Baker; Baker analyzed; CAS nr. 7722-84-1) was added 
to the solution. 100 ml solutions were treated with a low-pressure mercury UV lamp (Philips 
PLL60W) in a collimated beam apparatus. The distance between the lamp and the irradiated 
surface was 30 cm, doses applied were 0, 300, and 600 mJ/cm2. In another experiment first 
H2O2 and then ozone was added to a mixture of the pharmaceuticals, resulting in a 
concentration of 36 mg H2O2/L and an ozone dose of 12.5, 31.2 or 62.4 mg/L. The third 
experiment combined the same ozone doses with a UV dose of 120-150 mJ/cm2 in a flow-
through reactor equipped with a 90 W UV lamp. 
 2.3 Pilot experiments 
The pilot plant consisted of multi-layer filter column for particles and suspended solids 
removal from the WWTP effluent. The filter rate operated at a rate of 25 m/h. The filtration 
set-up was backwashed with filtered water (influent over a 150 µm filter) after reaching a 
maximum head loss setpoint. The filtered water was stored in a 1,000 L vessel, continuously 
flowing over near the WWTP effluent sampling point.  
The anion IEX unit consisted of two IEX vessels, each containing 25 L of Lanxess type 
Lewatit S6368A. The contact time of the water in the IEX was 2 minutes (flow 750 L/h). For 
the pilot experiments also a wide range of pharmaceuticals was added to the water, in 
concentrations of 1 – 5 µg/L (100 * the reporting limit of the analysis), also to be sure 
concentrations are high enough to determine significant degradation. Metabolites were 
analyzed, but had not been dosed to the water. The IEX treated water is, in case of dosage of 
the pharmaceuticals, fed to the UV/H2O2 set-up. The overflow of the IEX was discharged. 
After passage of 7,000 L of pretreated effluent water, the IEX was regenerated with an 
aqueous solution of about 10 wt-% NaCl (Broxo). After flushing the bed to remove the salty 
water, the IEX is ready to be used again. 
The UV/H2O2 set-up was operated discontinuously and only during the spiking of 
pharmaceuticals. Influent of the UV/H2O2 system was collected into the influent vessel of 200 
liters. Hydrogen peroxide was dosed manually into the vessel. The UV system was equipped 
with a low-pressure Amalgam lamp of 90 W in a M3 UV reactor system of PureBlue Water. 
During different tests, UV254 absorbance was measured and the dose of 150 or 300 mJ/cm² 
was set with a flow controlling system (flow ≤1 m3/h). The UV reactor also had been 
equipped with a 30 W Ultrasound (US) device. However, it was shown that this didn’t 
contribute to the conversion of pharmaceuticals (see supplementary information). A largely 
over-dimensioned granular activated carbon (GAC) filtration unit consisting of 2 columns 
filled with Norit activated carbon (type PK 1-3) was used to treat the pilot effluent water 
before discharging it to the surface water. The activated carbon filtration (ACF) is not used in 
this research to study the effects of ACF for the removal of pharmaceuticals.  
 
3. Results and Discussion 
 
3.1 Analyses of WWTP effluents 
The EfOM composition in various WWTP effluents is shown in Figure 2 (top). Clearly, the 
effluents from Garmerwolde, Panheel and Roermond contain significantly more EfOM than 
the other three effluents. This shows that “large” variations are possible. From Figure 2 
(bottom) it also can be concluded that all effluents contain significant amounts of 
pharmaceuticals. A detailed overview of all pharmaceuticals analyzed can be found in the 
supplementary information. The main compounds are Metformin and its transformation 
product Guanylurea (which is formed by the WWTP sludge), which appear in concentrations 
of > 10 μg/L (up to about 30 μg/L in Panheel). This clearly shows that the presence of 
pharmaceuticals in effluent, and thus in surface water, cannot be neglected. 
In the samples analyzed for this research pharmaceutical concentrations varied from about 25 
to 70 µg/L. By spiking the pharmaceuticals a total load < 40 µg/L was added, which means 
that the total concentration of pharmaceuticals still were in the same order of magnitude. As 
EfOM concentrations are a factor 1000 larger than the concentrations of pharmaceuticals, it is 
to be expected that this addition won’t have affected the processes themselves. 
 
3.2 Effect of pretreatment on EfOM composition 
Two types of pretreatment were studied: IEX and O3/biofiltration. Ozone can react with 
electron rich compounds, making them better biodegradable. This is shown in Table 1: the 
chemical oxygen demand (COD) of the water decreases upon ozone treatment, and even more 
after subsequent biofiltration. Furthermore, it can be observed that there is no significant 
change of the TOC content due to ozonation. Compounds may be degraded at the ozone dose 
used, but the reaction products will not disappear, contrarily to the effect of biodegradation. 
This also is reflected in the increase in UV-T upon ozonation and subsequent biofiltration. 
IEX results in a significant increase in UV-T too. The effect of a UV-T improvement on the 
energy demand of a UV/H2O2-process can be large, as can be concluded from Table 3 
(calculations based on the model of Bolton [21-23]). 
 
 
  
Figure 2: Composition of effluents. Upper panel: composition of EfOM. Lower Panel: total 
concentration of pharmaceuticals present (Summer 2014). More details on the type and 
concentrations of pharmaceuticals can be found in the supplementary information. 
 
Table 1: Effect of ozonation and subsequent biofiltration on the characteristics of the effluent 
of Roermond. HRT = hydraulic retention time in biofilter. 
 
Ozone 
concentration  
(mg/L) 
after O3 
 
HRT=15 min. HRT=30 min. 
 COD 
(mg/L) 
 
TOC 
(mg 
C/L 
UV-T 
(%) 
COD 
(mg/L) 
 
TOC 
(mg 
C/L 
UV-T 
(%) 
COD 
(mg/L) 
 
UV-T 
(%) 
0 62 20 22.7 40 10 40.8 35 47.5 
9.3 57 21 28.9 35 9.2 40.4 32 47.8 
18.6 51 21 34.2 33 11 48.4 29 51.2 
24.5 49 21 38.1 32 9.7 52 28 56.6 
 
 
Table 2: Effect of improvement in UV-T in Panheel effluent on relative energy demand of a 
UV-process. 
Type of water UV-T (%) Relative energy demand of UV 
process 
Effluent Panheel 38 100% 
After 
O3/biofiltratie 
69 38% 
After IEX 85 16% 
 
From Table 2 it can be concluded that it may be worthwhile to remove (part of) the EfOM in 
order to make a UV-process more energy efficient. 
The effect of ozone/biofiltration and IEX pretreatment on the EfOM composition in the 
Roermond and Panheel effluents is shown in Table 3.  
  
Table 3: Effect of pretreatment on the composition of effluent of Roermond and Panheel. 
 
Sample Process Process 
step 
HOC 
(μg/L) 
BP 
(μg/L) 
HS 
(μg/L) 
BB 
(μg/L) 
LMWn 
(μg/L) 
LMWa 
(μg/L) 
Total 
(μg/L) 
Roermond 
(06/2014) 
-- 
Effluent 1093 1544 7865 7031 3897 0 21430 
Roermond 
(09/2014) 
O3/biof. 
Effluent 2315 1236 12592 8315 4429 1 28888 
After O3 
(15.3 
mg/L) 
1194 1002 7486 4087 2824 1 16594 
After biof. 
(HRT 15 
1155 817 4980 2523 1298 1 10774 
min.) 
Total 
removal 
(%) 
50 34 60 70 70 0 63 
Panheel 
(06/2014) 
-- 
Effluent 1090 2595 4821 2443 3143 190 14282 
Panheel 
Lab. 
(09/2014) 
O3/biofil. 
Effluent 795 1162 4040 1251 1676 245 9169 
After 
O3/biof. 
(10 mg/L; 
HRT 6 
min.) 
0 606 2404 1033 895 53 4991 
Total 
removal 
100 48 40 17 47 78 46 
(%) 
IEX 
effluent 795 1162 4040 1251 1676 245 9169 
After IEX 365 891 0 471 916 304 2947 
Total 
removal 
(%) 
54 23 100 62 45 -- 68 
Panheel 
Pilot 
(01/2016) 
IEX 
effluent 2108 1953 5167 1995 2847 0 14070 
After 
filtration 
1935 1921 5105 2042 2859 0 13862 
After IEX 909 1960 0 1898 2379 792 7938 
Total 
removal 
(%) 
57 -- 100 5 16 -- 45 
 Table 3 shows that there can be large differences in effluent composition and content between 
WWTPs. Also between samples taken at different times large differences in composition at 
the same WWTP can be observed. Furthermore, in the Roermond sample ozone oxidizes 
about half of the HOC, HS and BB present, and about 19% of BP and 36% of LMWn. 
Additional biofiltration mainly removes LMWn (ca. 54%), and about 35% of HS and BB. In 
total about 45-65% of the EfOM can be removed applying O3/biofiltration. At the Panheel site 
100% of HOC was removed in Autumn 2014, and about 50% of BP, HS and LMWn. 
IEX removes 100% of HS, >50% of HOC, even though HOC was not expected to be charged. 
Like O3/biofiltration, IEX can also remove about 45-65% of the EfOM in total, although the 
composition of the resulting material differs in both cases. The multi-layer filtration hardly 
contributed to the removal of EfOM. For practical reasons, it was decided to continue 
experiments at the pilot plant with IEX as pretreatment. 
 
Pretreatment (by means of O3/biofiltration or IEX) may also affect the pharmaceuticals 
present in the effluent. To check this, a mixture of pharmaceuticals was added before 
pretreatment. The resulting removal is shown in Figure 3. 
 
 Figure 3: Removal of pharmaceuticals by pretreatment 
 
Obviously, compounds carrying a negative charge at this pH (ca. 7.5) can be effectively 
removed by IEX. As expected, also ozone/biofiltration can be very effective, depending on 
the compounds molecular structure.  
 
3.3 Effect of pretreatment on subsequent advanced oxidation processes 
 
The degradation of pharmaceuticals in WWTP effluent (without pretreatment) by three types 
of advanced oxidation processes (O3/H2O2, UV/H2O2 and UV/O3) is shown in Figure 4. For 
some compounds (salbutamol, propyphenazone, niacin, lincomycin, erythromycin A, 
caffeine, and sulfachloropyridzine) it seemed to be difficult to obtain reliable analyses, 
especially for the O3/H2O2 and the UV/H2O2 process. The problem didn’t seem to occur with 
the UV/O3 process. Possibly, the presence of other compounds in the effluent interfered with 
the analyses.  
In untreated effluent, with a very low UV-T, the O3/H2O2 process may be quite efficient. 
Under the conditions applied, most compounds show a conversion >80%. At the lowest O3 
dose only for diatrizoic acid, metformin and sulfachloropyridazine lower conversions were 
obtained, but they increased with increasing ozone dose. Partly the high conversions can be 
attributed to the relatively high H2O2 concentration of 36 mg/L, as from Figure 4 (right) it can 
be seen that even a concentration of 10 mg/L may already degrade diclofenac, furosemide, 
naproxen and phenazone to over 90% under these conditions. For the other compounds in the 
UV/H2O2 process obviously degradation increases with increasing UV dose, although not all 
compounds reach a degradation level ≥80%, as would be required. 
Remarkably, the UV/O3 process seems to give the highest degradation levels, even though the 
UV-T of the water is very low. Only for metformin degradation would be too low. 
 
To study the effect of the presence of EfOM on the removal of pharmaceuticals, IEX 
pretreatment was applied prior to both the O3/H2O2 and the UV/H2O2 process. The results of 
these experiments are shown in Figure 5. For the O3/H2O2 process the effect of removal of 
part of the EfOM is relatively small: only for some compounds, like cyclophosphamide and 
diatrizoic acid the process becomes significantly more efficient. However, it can be seen that 
the removal of a part of the EfOM largely affects the UV/H2O2 process. Furthermore, after 
IEX pretreatment a UV dose of 300 mJ/cm2 seems to be high enough to obtain sufficient 
removal of most pharmaceuticals tested. The amount of energy required to obtain this dose 
also has decreased significantly, according to Table 2. 
 
Based on these results it was decided to build a pilot set-up at the WWTP of Panheel, 
applying IEX as pretreatment and UV/H2O2 as AOP. The UV dose was set to either 150 or 
300 mJ/cm2. The results are shown in Figure 6. 
 Figure 4: Conversion of pharmaceuticals in untreated effluent by AOPs. Left: O3/H2O2 (36 mg H2O2/L); Middle: UV/O3; Right: UV/H2O2 
Figure 5: Effect of IEX on AOP in laboratory experiments. Left figure: O3/H2O2; right figure: UV/H2O2 
 
  
 
 
Figure 6: Total removal of pharmaceuticals by means of IEX, or IEX followed by UV/H2O2 
(150 and 300 mJ/cm2) in pilot experiments 
 
Again, it was found that the concentrations of most pharmaceuticals tested could be 
significantly decreased. For most compounds tested a UV dose of 150 mJ/cm2 would already 
be sufficient to obtain enough removal of pharmaceuticals. This is an extremely low UV dose 
for an AOP process, as even in drinking water production UV doses of about 500 mJ/cm2 are 
common in UV/H2O2 processes [20]. The effect of pretreatment can clearly be seen in the 
Electrical Energy per Order (EEO): 
𝐸𝐸𝑂 =  
𝑃
𝐹∗𝑙𝑜𝑔(
𝐶𝑖
𝐶𝑒
)
     eq. 1 
In this formula P is the electrical power (W), F is the flow through the reactor (m3 s-1), Ci is 
the concentration in the influent (mg L-1) and Ce is the concentration in the effluent (mg L
-1). 
The effect on EEO-values is shown in Figure 7: 
 
 
Figure 7: EEO values of UV/H2O2 process without pretreatment and after IEX (only 
compounds which had been removed <80% by IEX were considered) 
 
In Figure 7 only those compounds for which IEX showed a removal <80% were considered. 
This was done because otherwise EEO values are difficult to determine because concentrations 
reach the reporting limit. Obviously, the IEX pretreatment has a huge effect on the EEO 
values, and thus on the amount of energy required for the UV/H2O2 process. This shows that 
the presence of humic acids has a large effect on the efficiency of the UV/H2O2 process. 
 
3.4 Fate of metabolites 
 Special attention was paid to metabolites present in the effluent before and after treatment 
(supplementary information Tables supp-1 till supp-5 refer to the laboratory experiments, 
Table supp-6 to the pilot tests). A summary of the results is shown in Figure 8. As can be 
concluded from Table supp-1, the concentration of metabolites may vary largely with time. 
Treatment of the effluent with IEX may remove part of the metabolites, but it is not effective 
for O-desmethyltramadol, guanylurea, hydroxyl-ibuprofen and 10,11-trans-diol-
carbamazepine. O3/biolfiltration is more effective in the removal of metabolites, except for 
guanylurea and hydroxyl-ibuprofen (Table supp-2). The same conclusion can be drawn for the 
O3/H2O2 process, with or without IEX (Table supp-3), and the UV/O3 process (Table supp-4). 
Addition of only H2O2, with or without IEX pretreatment, resulted in an increase in the 
amount of carbamazepine-10,11-epoxide, but for all other metabolites analyzed the 
concentrations decreased. Probably, oxidation by H2O2 resulted in the formation of this 
metabolite. However, applying UV irradiation in combination with H2O2 resulted in a lower 
concentration of metabolites, the concentrations decreasing with increasing UV dose (Table 
supp-5). Similar results were obtained in the pilot set-up (Table supp-6 and Figure 8). Thus, it 
can be concluded that advanced oxidation, with or without pretreatment, did not result in the 
formation of known metabolites. 
 Figure 8: Fate of metabolites. Upper left: variations in WWTP effluent concentrations; upper 
middle: laboratory experiments with IEX or O3/biofiltration pretreatment; upper right: 
O3/H2O2 laboratory experiments with and without IEX; lower left: UV/H2O2  laboratory 
experiments with and without IEX; lower middle: O3/UV laboratory experiments; lower right: 
pilot experiments 
4. General discussion 
For the first time IEX followed by UV/H2O2 was tested as an additional treatment step for 
removing pharmaceutical compounds from biologically treated waste water effluent. The 
energy demand of the UV/H2O2 process decreases by 84% after application of IEX, making 
the process extremely attractive for application in practice.  
For the WWTP Panheel, an outline design for a full-scale application was made with a total 
capacity of 1,825 Mm3/year. Costs were calculated applying the Community of Practice Cost 
Calculator of RHDHV (www.kostenstandaard.nl) taking into account an additional pumping 
stage to create sufficient hydraulic head and ACF. The total extra costs would be about 
€0.34/m3 of treated effluent, including depreciation and operating costs. Recently, Mulder, 
Antakyali and Ante [24] compared processes studied in Germany and Switzerland, based on 
ozone, PAC or GAC, followed by rapid sand filtration (RSF), and calculated additional costs 
of about €0.30-0.40/m3, which are in the same order of magnitude. However, UV/H2O2 can be 
applied to remove a broad range of organic micropollutants, whereas ozonation converts 
mainly electron rich components, and ACF preferably adsorbs non-polar, hydrophobic 
compounds. Therefore, we expect that IEX followed by UV/H2O2 is more versatile. It is 
expected that the removal of the humic acid fraction, which accounts for about 50% of the 
total EfOM, will negatively affect surface water composition, on one hand because of the 
large variations in river discharge, which account for more than this difference, and on the 
other hand as humic acids are rather inert materials, which e.g. in soil are used to improve the 
textural quality of the soil [25]. 
 
5. Conclusions 
It was shown that WWTP effluent contains significant concentrations of pharmaceuticals (25-
65 μg/L) and about 10-20 mg C/L organic matter. By means of IEX mainly the humic acid 
fraction of the effluent organic matter can be removed, whereas O3/biofiltration mainly 
removes the hydrophobic fraction. IEX pretreatment results in an increase in UV-T from 38 to 
85%, resulting in a decrease in energy demand for the UV/H2O2 process of 84%. During pilot 
tests the IEX-UV/H2O2 process proved to be a robust process, able to remove a very broad 
range of different pharmaceuticals to a high extend. The additional costs for this treatment are 
estimated to be about €0.34/m3, which is in the same order of magnitude as was estimated for 
other additional treatment processes, like ozonation or ACF, followed by RSF.  
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